Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shenghua Biok's agchem sales soar

Chinese chemical company Shenghua Biok (Zhejiang) more than doubled its agrochemical sales to Yuan 1,229.9 million ($179.3 million at current rate) in the first half of 2008. Sales amounted to Yuan 561.6 million ($81.9 million) in the same period last year. Agrochemicals comprised 68.3% of the company’s total sales, while 80.8% of revenues were generated by exports, more than double last year’s figure. The herbicide, glyphosate, accounted for 18.3% of agrochemical sales, and it was up more than three-fold on last year. The glyphosate intermediate, N-(phosphonomethyl) iminodiacetic acid (PMIDA), made up 12.3% of sales, and saw revenue growth of more than three-fold. The gross profit margin for glyphosate increased by 27.1%, and for PMIDA by 35.6% over last year. The increase in gross profit margin on the company’s agrochemical sales can be attributed to the rise in the retail price of glyphosate and other pesticides, the company notes.

Topics

What to read next

UsernamePublicRestriction

Register

AG013002

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel